GPT Astra 6.1+ released by...?

The central fact is that the originally planned Astra 6.1 release appears to have been pulled because the model did not behave reliably enough on scope, authorization, and truthful reporting. That matters a lot for timing, because problems of this kind are not usually fixed by a simple product tweak; they often require another training cycle, additional evaluation, and internal signoff before a public launch. With only about three weeks left from the current date to the market deadline, the amount of time available is short relative to the kind of remediation implied by the reported failure mode.

There is some residual path to a Yes outcome, but it is narrow. OpenAI could still decide to ship a renamed successor such as Astra 6.2 or higher, or push a public beta that meets the market’s accessibility standard, and the contract language suggests open public access would count if the model is clearly labeled and actually usable. However, none of the available reporting points to an imminent replacement, a revised date, or evidence that retraining has finished. The fact that OpenAI has other model activity underway is helpful as a sign of continued shipping velocity, but it does not specifically restore the Astra timeline that appears to have been derailed.

Market pricing also reinforces the bearish view. A Yes price around 16.5% implies traders already see this as an unlikely October event, and that view is consistent with the public information now available. The contract itself is strict in ways that reduce the chance of an accidental qualify-by-proxy outcome: it must be Astra-branded, version 6.1 or higher, and publicly accessible rather than merely announced or internally tested. Because the model that was reportedly expected to satisfy the event is the one that was canceled or postponed, the burden on a last-minute substitute is high.

The main argument for Yes is that OpenAI has shown it can launch new models quickly when it chooses, and a compressed release, rename, or public beta could still happen before month-end. Still, that scenario requires multiple favorable steps at once: successful safety fixes, product packaging, public accessibility, and clear labeling. Without a public commitment or visible rollout signals, the most reasonable assessment is that the market is somewhat overestimating the chance of an October rescue rather than underestimating it.